Anteris Technologies touts first successful implant of DurAVR THV in valve-in-valve procedure

The DurAVR THV. [Image from Anteris Technologies]Anteris Technologies announced today that surgeons used its DurAVR heart valve for the first time in a valve-in-valve (ViV) procedure.

Brisbane, Australia-based Anteris — which has U.S. operations in Minneapolis — designed TurAVR THV as a new class of biomimetic heart valve. The company says it’s the world’s only balloon-expandable, single-piece transcatheter aortic valve shaped to mimic a native human aortic valve’s performance.

Balloon-expandable delivery enables precise alignment with the heart’s native commissures, achieving desired valve positioning.

The first ViV use of the valve came as part of Health Canada’s Special Access Program (SAP). Dr. Anita Asgar, co-director of the structural heart program at the Institut de Cardiologie de Montreal, made the SAP request. She wanted to use the Anteris valve for a patient with a failing valve and short frame height. According to An…

Read more
  • 0